Company Filing History:
3 out of 2,615 
3 out of 243 
1 out of 832,966 Years Active: 1996-2001
Title: The Innovative Contributions of Phillip Scott
Introduction
Phillip Scott is a notable inventor based in Swarthmore, PA (US). He has made significant contributions to the field of vaccine development, particularly through his innovative use of Interleukin-12 as an adjuvant. With a total of 4 patents, his work has the potential to enhance immune responses against various pathogens and cancers.
Latest Patents
One of Phillip Scott's latest patents focuses on "Compositions and methods for use of IL-12 as an adjuvant." This patent describes improved vaccine compositions characterized by an antigen from a pathogen and an effective adjuvanting amount of Interleukin-12. These IL-12 adjuvanted vaccines are designed to increase the vaccinated host's cell-mediated immune response, thereby providing a more robust and protective immune response to the pathogen. The patent also outlines methods for vaccinating hosts by administering a vaccine containing an antigen from a pathogenic microorganism alongside an adjuvanting amount of IL-12. Additionally, vaccines or therapeutic compositions aimed at cancer treatment may also benefit from IL-12 adjuvanting according to this invention.
Career Highlights
Phillip Scott has had a distinguished career, working with prestigious institutions such as the University of Pennsylvania and The Wistar Institute. His research has focused on enhancing vaccine efficacy and developing innovative methods for immunization.
Collaborations
Phillip Scott has collaborated with notable figures in his field, including Giorgio Trinchieri. Their joint efforts have contributed to advancements in vaccine research and development.
Conclusion
Phillip Scott's innovative work in vaccine development, particularly through the use of Interleukin-12, showcases his commitment to enhancing public health. His contributions are paving the way for more effective vaccines and therapeutic options.